Specific properties and effect of perindopril in controlling the renin-angiotensin system

American Journal of Hypertension

Volumn 18, Issue 9 SUPPL., 2005, Pages 142-154

  Ferrari, R ^a   Pasanisi, G ^b   Notarstefano, P ^b   Campo, G ^b   Gardini, E ^b   Ceconi, C ^b  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b NONE

Author keywords

Angiotensin II; Angiotensin converting enzyme inhibition; Bradykinin; Cardiovascular disease; Perindopril

Indexed keywords

AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ ANTAGONIST; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; ENALAPRILAT; HYDROCHLOROTHIAZIDE; ICATIBANT; INDAPAMIDE; LISINOPRIL; METOPROLOL; NIFEDIPINE; NITRENDIPINE; PERINDOPRIL; PERINDOPRILAT; RAMIPRIL; VASODILATOR AGENT;

ALLERGIC REACTION; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE ACTIVITY; ASTHENIA; BLOOD PRESSURE REGULATION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; COUGHING; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TACHYCARDIA;

EID: 23944468729     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.05.037     Document Type: Article

References (122)

1. K.M. Fox Management of coronary artery disease implications of the EUROPA trial Br J Cardiol 11 2004 195 204
2. H.D. White Should all patients with coronary disease receive angiotensin-converting enzyme inhibitors? Lancet 362 2003 755 757
3. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
4. N.J. Brown, D.E. Vaughan Angiotensin-converting enzyme inhibitors Circulation 97 1998 1411 1420
5. R. Ferrari Preserving bradykinin or blocking angiotensin II the cardiovascular dilemma Dialog Cardiovasc Med 9 2004 71 89
6. M. Vincent, B. Marchand, G. Remond, S. Jaguelin-Guinamant, G. Damien, B. Portevin, J.Y. Baumal, J.P. Bouchet, P.H. Lambert Synthesis and ACE inhibitory activity of the stereoisomers of perindopril (S-9490) and perindoprilate (S-9780) Drug Des Discov 9 1992 11 28
7. M. Hurst, B. Jarvis Perindopril an updated review of its use in hypertension Drugs 61 2001 867 896
8. l receptor, and nitric oxide synthase expression in patients with coronary heart disease Hypertension 39 2002 634 638
9. W.J. Louis, E.L. Conway, H. Krum, H. Krum, B. Workman, O.H. Drummer, W. Lam, P. Philips, L.G. Howes, B. Jackson Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril Clin Exp Pharmacol Physiol 19 Suppl 1992 55 60
10. C. Johnston, B. Fabris, H. Yamada, F.A. Mendelsohn, R. Cubela, D. Sivell, B. Jackson Comparative studies of tissue inhibition by angiotensin-converting enzyme inhibitors J Hypertens 7 Suppl 5 1989 S11 S16
11. J.P. Bussien, T.F. d'Amore, L. Perret, M. Porchet, J. Nussberger, B. Waeber, H.R. Brunner Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects Clin Pharmacol Ther 39 1986 554 558
12. B. Jackson, R.B. Cubela, C.I. Johnston Inhibition of tissue angiotensin-converting enzyme by perindopril in vivo assessment in the rat using radioinhibitor binding displacement J Pharmacol Exp Ther 245 1988 950 955
13. K. Sakaguchi, B. Jackson, S.Y. Chai, F.A. Mendelsohn, C.I. Johnson Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography J Cardiovasc Pharmacol 12 1988 710 717
14. K. Sakaguchi, S.Y. Chai, B. Jackson, C.I. Johnston, F.A. Mendelsohn Differential angiotensin-converting enzyme inhibition in the brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography Neuroendocrinology 48 1988 223 228
15. S.H. Andreatta, D.B. Averill, R.A. Santos, C.M. Ferrario The ventrolateral medulla. A new site of action of the renin-angiotensin system Hypertension 11 1988 I163 I166
16. M.J. Phillips, B. Kimura Converting enzyme inhibitors and brain angiotensin J Cardiovasc Pharmacol 8 1986 582 590
17. T. Unger, D. Genten, R.E. Lang Tissue-converting enzyme and cardiovascular actions of converting enzyme inhibitors J Cardiovasc Pharmacol 8 Suppl 10 1986 S75 S581
18. K.R. Lees, J.L. Reid Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjects J Cardiovasc Pharmacol 10 1987 129 135
19. K.R. Lees, J.L. Reid Hemodynamic and humoral effects of oral perindopril, an angiotensin-converting enzyme inhibitor, in man Br J Clin Pharmacol 23 1987 159 164
20. J. Bidiville, M. Porchet, J.P. Bussien, J. Nussberger, B. Waeber, H.R. Brunner Effect of 8-day converting enzyme inhibition on ambulatory blood-pressure recordings in normotensive volunteers Arch Int Pharmacodyn Ther 288 1987 109 119
21. C. Richer, C. Thuillez, J.F. Giudicelli Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer J Cardiovasc Pharmacol 9 1987 94 102
22. C.F. Dollery, R.C. Causon, M.J. Brown Long-lasting inhibition of ACE and angiotensin I pressor responses by S9490 in healthy volunteers Ricerca Sci Educ Perm 34 1985 181 186
23. Y. Hui, Z. Dai, X. Chen, W. Wang Effect of perindopril and metoprolol on left ventricular hypertrophy and performance in essential hypertension Chin Med J (Engl) 108 1995 678 681
24. E. Agabiti-Rosei, E. Ambrosioni, G. Finardi, P. Folino, G. Galbassi, P. Malini, E. Marchesi, M.L. Muiesan, A. Semplicini, A.C. Pessina Perindopril versus captopril efficacy and acceptability in an Italian multicenter trial Am J Med 92 1992 S79 S83
25. A.M. Grandi, A. Venco, F. Barzizza, E. Petrucci, F. Scalise, G. Perani, E. Marchesi, P. Folino, G. Finardia Double-blind comparison of perindopril and captopril in hypertension effects on left ventricular morphology and function Am J Hypertens 4 1991 516 520
26. Agabiti-Rosei E, Cores L, Leonetti G: A double-blind assessment, perindopril vs. verapamil, of the effects on office BP and 24-h ambulatory BP on left ventricular morphology; Annual Meeting of the European Society of Hypertension 1995; Abstract 106.
27. A. Pellacani, H.R. Brunner, J. Nussberger Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects Clin Sci (Lond) 87 1994 567 574
28. D.J. Campbell, A. Kladis, A.M. Duncan Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides Hypertension 23 1994 439 449
29. 2 receptor antagonism attenuates BP response to acute angiotensin-converting enzyme inhibition in normal men Hypertension 36 2000 132 136
30. T. Morishita, M. Tsutsi, H. Shimokawa, H. Tasaki, O. Suda, K. Kobayashi, M. Horiuchi, H. Okuda, Y. Tsuda, N. Yanagihara, Y. Nakashima Long-term treatment with perindopril ameliorated dobutamine-induced myocardial ischemia in patients with coronary artery disease Jpn J Pharmacol 88 2002 100 107
31. K.M. Fox EUROPA investigators Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease randomized, double-blind, placebo-controlled, multicenter trial (the EUROPA study) Lancet 362 9386 2003 782 788
32. Ferrari R: PERTINENT: PERindopril, Thrombosis, InflammatioN, Endothelial dysfunction and Neurohormonal activation Trial, a sub-analysis of EUROPA European Society of Cardiology Annual Congress. Munich, Germany; 28 August-l September 2004 (Abstract 2585).
33. M.E. Safar, G.M. London, G.E. Plante Arterial stiffness and kidney function Hypertension 43 2004 163 168
34. R.G. Asmar, B. Pannier, J.P. Santoni, S. Laurent, G.M. London, B.I. Levy, M.E. Safar Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension Circulation 78 1988 941 950
35. N.K. Thybo, N. Stephens, A. Cooper, C. Aalkjaer, A.M. Heagerty, M.J. Mulvany Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension Hypertension 25 1995 72 81
36. N.H. Buus, M. Bottcher, C.G. Jorgensen, K.L. Christensen, K. Thygesen, T.T. Nielsen, M.J. Mulvany Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or β-blockade in patients with essential hypertension Hypertension 44 2004 465 470
37. M.J. Kool, F.A. Lustermans, J.G. Breed, H.A. Struijker Boudier, A.P. Hoeks, R.S. Reneman, L.M. Van Bortel The influence of perindopril and the diuretic combination amiloride-hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients J Hypertens 13 1995 839 848
38. B. Schwartzkopff, M. Brehm, M. Mundhenke, B.E. Strauer Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease Hypertension 36 2000 220 225
39. A.P. Guérin, J. Blacher, B. Pannier, S.I. Marchais, M.E. Safar, G.M. London Impact of aortic stiffness attenuation on survival of patients in end stage renal failure Circulation 103 2001 987 992
40. A.M. Grandi, M. Bignoni, G. Gaudio, P. Zanzi, L. Guasti, A. Venco Ambulatory blood pressure and left ventricular changes during antihypertensive treatment perindopril versus isradipine J Cardiovasc Pharmacol 26 1995 737 741
41. M. Moroi, L. Zhang, T. Yasuda, R. Virmani, H.K. Gold, M.C. Fishman, P.L. Huang Interaction of genetic deficiency of endothelial nitric oxide, gender and pregnancy in vascular response to injury in mice J Clin Invest 101 1998 1225 1232
42. G.B. Mancini, G.C. Henry, C. Macaya, B.J. O'Neill, A.L. Pucillo, R.G. Carere, T.J. Wargovich, H. Mudra, T.F. Luscher, M.I. Klibaner, H.E. Haber, A.C. Uprichard, C.J. Pepine, B. Pitt Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study Circulation 94 1996 258 265
43. F. Diet, R.E. Pratt, G.J. Berry, N. Momose, G.H. Gibbons, V.J. Dzau Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease Circulation 94 1996 2756 27667
44. I. Antony, G. Lerebours, A. Nitenberg Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients Circulation 94 1996 3115 3122
45. P. Fennessy, J. Campbell, F. Mendelsohn, G.R. Campbell Angiotensin-converting enzyme inhibitors and atherosclerosis relevance of animal models to human disease Clin Exp Pharmacol Physiol 23 Suppl l 1996 S30 S32
46. R. Candido, K.A. Jandeleit-Dahm, Z. Cao, S.P. Nesteroff, W.C. Burns, S.M. Twigg, R.J. Dilley, M.E. Copper, T.J. Allen Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice Circulation 106 2002 246 253
47. R. Fogari, A. Mugellini, A. Zoppi, L. Corradi, P. Preti, P. Lazzari, G. Derosa Losartan and perindopril effects on plasma plasminogen activator inhibitor-l and fibrinogen in hypertensive type 2 diabetic patients Am J Hypertens 15 2002 316 320
48. Y. Erdem, C. Usalan, I.C. Haznedaroglu, B. Altun, M. Arici, U. Yasavul, C. Turgan, S. Caglar Effects of angiotensin-converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension Am J Hypertens 12 1999 1071 1076
49. G. Yasuda, K. Hasegawa, T. Kuji, N. Ogawa, G. Shimura, S. Umemura, O. Tochikubo Perindopril effects on ambulatory blood pressure relation to sympathetic nervous activity in subjects with diabetic nephropathy Am J Hypertens 17 2004 14 20
50. Heart Failure Society of America (HSFA) HFSA guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction - pharmacological approaches Congest Heart Fail 6 2000 11 40
51. G.L. Bartels, F.M. van den Heuvel, D.J. van Veldhuisen, M. van der Ent, W.J. Remme Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function Am J Cardiol 83 1999 332 336
52. M.R. Walters, J.L. Reid Perindopril J Drug Eval 1 2003 115 141
53. C. Speirs, F. Wagniart, L. Poggi Perindopril postmarketing surveillance a 12 month study in 47,351 hypertensive patients Br J Clin Pharmacol 46 1998 63 70
54. S. Julius, J.N. Cohn, J. Neutel, M. Weber, P. Turlapaty, Y. Shen, V. Dong, A. Batchelor, H. Lagast Antihypertensive utility of perindopril in a large, general practice-based clinical trial J Clin Hypertens 6 2004 10 17
55. W. Guo, P. Turlapaty, Y. Shen, V. Dong, A. Batchelor, D. Barlow, H. Lagast Clinical experience with perindopril in patients nonresponsive to previous antihypertensive therapy a large US community trial Am J Ther 11 2004 199 205
56. J.N. Cohn, S. Julius, J. Neutel, M. Weber, P. Turlapaty, Y. Shen, V. Dong, A. Batchelor, W. Guo, H. Lagast Clinical experience with perindopril in African-American hypertensive patients a large USA community trial Am J Hypertens 17 2004 134 138
57. A. Fenves, C.V. Ram Are angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers becoming the treatment of choice in African-Americans? Curr Hypertens Rep 4 2002 286 289
58. K.R. Lees, J.L. Reid, M.G. Scort, J. Hosie, D. Herpin, J.P. Santoni Captopril versus perindopril a double-blind study in essential hypertension J Hum Hypertens 3 1989 17 22
59. L. Alcocer, C. Campos, J.H. Bahena, A. Nacaud, J. Parra Carillo, C. Calvo, C. Weber, G. Lerebours, L. Mickalonis, M.T. Villahermosa Clinical acceptability of ACE inhibitor therapy in mild-to-moderate hypertension, a comparison between perindopril and enalapril Cardiovasc Drugs Ther 9 1995 431 436
60. K. Yusoff, T.A. Razak, N. Yusof, N.M. Rafee Comparative efficacy of perindopril and enalapril once daily using 24-h ambulatory blood pressure monitoring Int J Clin Pract 53 1999 277 280
61. K. Yoshinaga, T. Saruta, K. Abe Clinical evaluation of monotherapy with perindopril in the treatment of hypertension a double-blind parallel comparison with enalapril Rinshu Fyaku 13 1997 4259 4297
62. J. Polonia, M. Pego A double-blind comparison of perindopril and enalapril on 24-h control of blood pressure Am J Hypertens 9 1996 162
63. F. Zannad, C.M. Bernaud, R. Fay General Physicians Investigators' Group Double-blind, randomized, multicenter comparison of the effects of amlodipine and perindopril on 24-h therapeutic coverage and beyond in patients with mild-to-moderate hypertension J Hypertens 17 1999 137 146
64. Canadian Study Group on Perindopril Once-daily perindopril versus slow release diltiazem in the treatment of mild-to-moderate essential hypertension Can J Cardiol 10 Suppl D 1994 D8 D12
65. H. Thurston, A. Mimran, A. Zanchetti, G. Creytens, G. Rorive, C.L. Brown, J.P. Santoni A double-blind comparison of perindopril and atenolol in essential hypertension J Hum Hypertens 4 1990 547 552
66. T.O. Morgan, W.J. Louis, G.J. MacDonald, E.L. Conway, L.C. Bartholomeusz, A.I. Anderson, D.P. Cameron, T. Donnelly, D.B. Frewin, M.J. Hooper Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension results of a double-blind multicenter study versus atenolol Am J Med 92 1992 S73 S78
67. R. Kuperstein, Z. Sasson Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass a randomized, double-blind, controlled study of 21 obese hypertensives Circulation 102 2000 1802 1806
68. Guidelines Sub-Committee World Health Organization-International Society of Hypertension Guidelines for the management of hypertension Blood Press 8 Suppl 1999 9 43
69. B. Williams, N.R. Poulter, M.J. Brown, M. Davis, G.T. McInnes, J.F. Potter, P.S. Sever, S.M. Thom BHS guidelines working party, for the British Hypertension Society British Hypertension Society guidelines for hypertension management 2004 (BHS-IV) summary Br Med J 328 2004 634 640
70. Physician's Desk Reference 55th ed 2001 Thompson Healthcare Montvale, NJ
71. M.G. Myers Perindopril Multicenter Dose-Response Study Group A dose-response study of perindopril in hypertension effects on blood pressure 6 and 24 h after dosing Can J Cardiol 12 1996 1191 1196
72. K.W. Tan, F.H.H. Leenen Persistence of antihypertensive effect after missed dose of perindopril Br J Clin Pharmacol 48 1999 628 630
73. T. Morgan, A. Anderson Duration of antihypertensive effect of perindopril (P), enalapril (E), and captopril Hypertension 21 1993 568
74. M.K. Davies, C.R. Gibbs, G.Y.H. Lip ABC of heart failure: Management: diuretics, ACE inhibitors and nitrates BMJ 320 2000 428 431
75. W.J. Remme, K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure Eur Heart J 22 2001 1527 1560
76. P. Desche, I. Antony, G. Lerebours, I. Violet, S. Robert, C. Weber Acceptability of perindopril in mild-to-moderate chronic congestive heart failure. Results of a long-term open study in 320 patients Am J Cardiol 71 1993 E61 E68
77. P. Lechat, S.P. Garnham, P. Desche, J.P. Bounhoure Efficacy and acceptability of perindopril in mild-to-moderate chronic congestive heart failure Am Heart J 126 1993 798 806
78. J.P. Bounhoure, G. Bottineau, P. Lechat, J. Garnham, G. Lapeyre Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study Clin Exp Hypertens 11 Suppl 2 1989 575 586
79. I.B. Squire, R.J. MacFadyen, J.L. Reid, A. Devlin, K.R. Lees Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure J Cardiovasc Pharmacol 27 1996 657 666
80. J.L. Reid, R.J. MacFadyen, I.B. Squire, K.R. Lees Angiotensin-converting enzyme inhibitors in heart failure blood pressure changes after the first dose Am Heart J 126 1993 794 797
81. N.T. Navookarasu, A.R. Rahman, I. Abdullah First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure a Malaysian experience Int J Clin Pract 53 1999 25 30
82. L. Anthopoulos, T. Apostolou, P. Bonoris, S. Foussas, N. Lefkos, S. Zombolos Comparative hemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure Curr Med Res Opin 17 2001 290 297
83. J. Vitovec, J. Spinar First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure a comparison of enalapril and perindopril Eur J Heart Fail 2 2000 299 304
84. R.J. MacFadyen, C.S. Barr, N.D.C. Sturrock, M. Fenwick, A.D. Struthers Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure Br J Clin Pharmacol 44 1997 69 76
85. L. Ghiadoni, A. Magagna, D. Versari, I. Kardasz, Y. Huang, S. Taddei, A. Salvetti Different effects of antihypertensive drugs on conduit artery endothelial function Hypertension 41 2003 1281 1286
86. R.E. Schmieder, P. Martus, A. Klingbeil Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies JAMA 275 1996 1507 1513
87. R. Ferrari PREAMI Investigators PREAMI: Perindopril and Remodeling in the Elderly with Acute Myocardial Infarction: study rationale and design Cardiovasc Drugs Ther 14 2000 671 679
88. M.D. Flather, S. Yusuf, L. Kober, M. Pfeffer, A. Hall, G. Murray, C. Torp-Pedersen, S. Ball, J. Pogue, L. Moye, E. Braunwald Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction a systematic overview of data from individual patients Lancet 355 2000 1575 1581
89. C.P. Lau, H.F. Tse, W. Ng, K.K. Chan, S.K. Li, K.K. Keung, Y.K. Lau, W.H. Chen, Y.W. Tang, S.K. Leung Comparison of perindopril versus captopril for treatment of acute myocardial infarction Am J Cardiol 89 2002 150 154
90. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
91. Eastern Stroke and Coronary Heart Disease Collaborative Research Group Blood pressure, cholesterol and stroke in eastern Asia Lancet 352 1998 1801 1807
92. A. Hartmann, T. Rundek, H. Mast, M.C. Paik, B. Boden-Albala, J.P. Mohr, R.L. Sacco Mortality and causes of death after first ischemic stroke the Northern Manhattan Stroke Study Neurology 57 2001 2000 2005
93. H. Bronnum-Hansen, M. Davidsen, P. Thorvaldsen Danish MONICA Study Group Long-term survival and causes of death after stroke Stroke 32 2001 2131 2136
94. R. Kelly, A. Staines, R. MacWalter, P. Stonebridge, H. Tunstall-Pedoe, A.D. Struthers The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes a case-control study J Am Coll Cardiol 39 2002 219 224
95. PROGRESS Collaborative Group Randomized trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack Lancet 358 2001 1033 1041
96. PROGRESS Collaborative Group Effects of a perindopril-based blood-pressure-lowering regimen on cardiac outcomes among patients with cerebrovascular disease Eur Heart J 24 2003 475 484
97. C.M. Lawes, D.A. Bennett, V.L. Feigin, A. Rodgers Blood pressure and stroke an overview of published reviews Stroke 35 2004 776 785
98. N. Chapman, R. Huxley, C. Anderson, M.G. Bousser, J. Chalmers, S. Colman, S. Davis, G. Donnan, S. MacMahon, B. Neal, C. Warlow, M. Woodward Writing Committee for the PROGRESS Collaborative Group Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history the PROGRESS Trial Stroke 35 2004 116 121
99. K. Berthet, B.C. Neal, J.P. Chalmers, S.W. MacMahon, M.G. Bousser, S.A. Colman, M. Woodward Perindopril Protection Against Recurrent Stroke Study Collaborative Group Reductions in the risks of recurrent stroke in patients with and without diabetes the PROGRESS Trial Blood Press 13 2004 7 13
100. A. Rodgers, N. Chapman, M. Woodward, L.S. Liu, S. Colman, A. Lee, J. Chalmers, S. MacMahon Perindopril Protection Against Recurrent Stroke Study Collaborative Group Perindopril-based blood-pressure lowering in individuals with cerebrovascular disease consistency of benefits by age, sex and region J Hypertens 22 2004 653 659
101. PROGRESS Collaborative Group Effects of blood-pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch Intern Med 163 2003 1069 1075
102. PROGRESS Collaborative Group Effects of a perindopril-based blood-pressure lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease A randomized clinical trial Stroke 34 2003 2333 2338
103. A.G. Dyker, D.G. Grosset, K. Lees Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke Stroke 28 1997 580 583
104. F.S. Nazir, J.R. Overell, A. Bolster, T.E. Hilditch, K.R. Lees Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke a randomized controlled trial Cerebrovasc Dis 19 2005 77 83
105. M.R. Walters, A. Bolster, A.G. Dyker, K.R. Lees Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease Stroke 32 2001 473 478
106. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
107. SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators N Engl J Med 327 1992 685 691
108. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
109. AIRE Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators Lancet 342 1993 821 828
110. L. Kober, C. Torp-Pedersen, J.E. Carlsen, H. Bagger, P. Eliasen, K. Lyngborg, J. Videbaek, D.S. Cole, L. Audert, N.C. Pauly TRAndolapril Cardiac Evaluation (TRACE) Study Group A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 333 1995 1670 1676
111. R.J. Gibbons, J. Abrams, K. Chatterjee, J. Daley, P.C. Deedwania, J.S. Douglas, T.B. Ferguson Jr, S.D. Fihn, T.D. Fraker Jr, J.M. Gardin, R.A. O'Rourke, R.C. Pasternak, S.V. Williams, R.J. Gibbons, J.S. Alpert, E.M. Antman, L.F. Hiratzka, V. Fuster, D.P. Faxon, G. Gregoratos, A.K. Jacobs, S.C. Smith Jr American College of Cardiology, American Heart Association Task Force on Practice Guidelines ACC/AHA 2002 Guidelines Update for the Management of patients with chronic stable angina. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 107 2003 149 158
112. Guidelines Committee 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 21 2003 1011 1053
113. American Diabetes Association Treatment of hypertension in adults with diabetes Diabetes Care 26 Suppl 1 2003 S80 S82
114. A.I. Adler, I.M. Stratton, H.A. Neil, J.S. Yudkin, D.R. Matthews, C.A. Cull, A.D. Wright, R.C. Turner, R.R. Holman Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36) prospective observational study Br Med J 321 2000 412 419
115. G.F. Strippoli, M. Craig, J.J. Deeks, F.P. Schena, J.C. Craig Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy a systematic review BMJ 329 2004 828
116. P. Fressinaud, G. Berrut, H. Gallois Antihypertensive action, clinical and biological acceptability of perindopril main results in 23,460 patients with mild to moderate hypertension treated for 6 months in general practice Ann Cardiol Angiol (Paris) 42 1993 51 59
117. J. Kvetny, G. Gregersen, R.S. Pedersen Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus Q J Med 94 2001 89 94
118. G. Jerums, T.J. Allen, D.J. Campbell, M.E. Cooper, R.E. Gilbert, J.J. Hammond, J. Raffaele, C. Tsalamandris Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria Am J Kidney Dis 37 2001 890-S99
119. A. Nakervis, K. NIcholls, G. Kilmartin, P. Allen, S. Ratnaike, F.I. Martin Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria a 3-year placebo-controlled biopsy study Metabolism 47 12 Suppl 1 1998 12 15
120. J.S. Silberberg, P.E. Barre, S.S. Prichard, A.D. Sniderman Impact of left ventricular hypertrophy on survival in end stage renal disease Kidney Int 36 1989 286 290
121. J. Blacher, B. Pannier, A.P. Guerin, S.I. Marchais, M.E. Safar, G.M. London Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end stage renal disease Hypertension 32 1998 570 574
122. J. Blacher, A.P. Guerin, B. Pannier, S.I. Marchais, M.E. Safar, G.M. London Impact of aortic stiffness on survival in end stage renal disease Circulation 99 1999 2434 2439